Medicinal product name Panadol Extra optizorb 500 mg/65 mg film-coated tablets
Pharmaceutical form Film-coated tablet
Strength 500 mg/65 mg 
Information from the MAH on shortages Not available
predicted availability date: not notified
Legal status OTC OTC
Package leafletMS Word document 28-03-2019
Summary of product characteristicsMS Word document 28-03-2019
ATC code N02BE51 Analgesics

Medicinal products (7)

Availability of medicinal product Wholesalers Package size, content Primary packaging Maximum admissible pharmacy price (€ incl. VAT) Product No. Labelling
 Not available (according to the information provided by wholesalers) currently no information on availability from any wholesaler N8
(500 mg/65 mg)
PVC/Al blister    13-0119-01 Labelling text Labelling text Mar 28, 2019
 Not available (according to the information provided by wholesalers)
predicted availability date: not notified
currently no information on availability from any wholesaler N12
(500 mg/65 mg)
PVC/Al blister    13-0119-02 Labelling text Labelling text Mar 28, 2019
 Not available (according to the information provided by wholesalers) currently no information on availability from any wholesaler N32
(500 mg/65 mg)
PVC/Al blister    13-0119-03 Labelling text Labelling text Mar 28, 2019
 Not available (according to the information provided by wholesalers) currently no information on availability from any wholesaler N14
(500 mg/65 mg)
Carton/PVC box    13-0119-04 Labelling text Labelling text Mar 28, 2019
 Not available (according to the information provided by wholesalers) currently no information on availability from any wholesaler N8
(500 mg/65 mg)
PVC/PET/AL blister    13-0119-05 Labelling text Labelling text Mar 28, 2019
 Not available (according to the information provided by wholesalers) currently no information on availability from any wholesaler N12
(500 mg/65 mg)
PVC/PET/AL blister    13-0119-06 Labelling text Labelling text Mar 28, 2019
 Not available (according to the information provided by wholesalers) currently no information on availability from any wholesaler N32
(500 mg/65 mg)
PVC/PET/AL blister    13-0119-07 Labelling text Labelling text Mar 28, 2019

Registration information

Marketing authorisation No. 13-0119
Date of authorisation May 15, 2013
MA valid until For unlimited time
Marketing authorisation holder, country GlaxoSmithKline Dungarvan Ltd., Ireland